Just because a molecular target resides inside a cancer cell does not mean that it cannot be targeted by antibodies, says Qi Zeng, founder of A*STAR spin-off company Intra-ImmuSG.
Jingmei Li is developing a risk scoring system for breast cancer that could help clinicians formulate better screening programs to catch the disease in its early stages.
DNA damage associated with premature aging in Hutchinson-Gilford Progeria Syndrome can be prevented if the abnormal protein progerin is removed before DNA replication.
A*STAR researchers have found a way to arrest distributed-denial-of-service attacks close to their source, with implications for securing the Industrial Internet of Things.